KRAS-specific antibody binds to KRAS protein inside colorectal adenocarcinoma cells and inhibits its localization to the plasma membrane
10.3389/fonc.2023.1036871
Saved in:
Main Authors: | Lam, KK, Low, YS, Lo, M, Wong, M, Leong Tang, C, Tan, E, Chok, AY, Seow-En, I, Wong, SH, Cheah, PY |
---|---|
Other Authors: | MICROBIOLOGY AND IMMUNOLOGY |
Format: | Article |
Published: |
Frontiers Media SA
2024
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/248902 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma
by: Pang, N.K.B., et al.
Published: (2014) -
CHARACTERIZTION OF LoxP-krasV12 TRANSGENIC ZEBRAFISH FOR INTESTINE SPECIFIC TUMORIGENESIS
by: ANEEKET JETLEY
Published: (2023) -
Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
by: Lam, KK, et al.
Published: (2024) -
<i>KRAS</i> mutation-independent downregulation of MAPK/PI3K signaling in colorectal cancer
by: Lam, Kuen Kuen, et al.
Published: (2024) -
A subset of flavaglines inhibits KRAS nanoclustering and activation
by: Yurugi, Hajime, et al.
Published: (2021)